Verification evidence is still being completed.
PDF / print export
Gubra
Horsholm, Denmark
- Verified lead
- Henrik Blou
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- CEO
- 2026 technical specialization
- Preclinical CRO, Metabolic Disease Models, Peptide Therapeutics, and Drug Discovery Support
- Review cycle
- May 2026
- Full address
- Horsholm Kongevej 11B, 2970 Horsholm, Denmark
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Gubra contact page confirming the Horsholm address.
- Editorial note
- Gubra is published because official company materials confirm current leadership, Horsholm operating footprint, and a clear preclinical CRO and therapeutics platform.
Preclinical CRO, Metabolic Disease Models, Peptide Therapeutics, and Drug Discovery Support
Official investor leadership disclosure, Official Horsholm contact disclosure, Preclinical CRO operating claim
Gubra is published because official company materials confirm current leadership, Horsholm operating footprint, and a clear preclinical CRO and therapeutics platform.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated05 Jun 2026, 01:06
Gubra runs preclinical studies, metabolic disease models, and drug discovery support in Horsholm, Denmark.
Contact & location
- Website
- gubra.dk
- Company page
- Lead
- Henrik Blou (verified ↗)
- Compliance
- Not yet on record
- Last reviewed
- 21 Mar 2026 (3mo ago)
- Scale
- Commercial preclinical CRO platform
- Capabilities
- Preclinical Studies · Metabolic Disease Models · Drug Discovery Support
- Founded
- 2008
- Headcount
- 201-500
Clinical profileSTATUS: VERIFIED MARCH 2026
Henrik Blou
CEO
Full addressHorsholm Kongevej 11B, 2970 Horsholm, Denmark
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source
Official Gubra contact page listing the Horsholm Kongevej 11B address.
Open sourceCommercial preclinical CRO platform
Horsholm, Denmark. Preclinical CRO, Metabolic Disease Models, Peptide Therapeutics, and Drug Discovery Support. Review completed on 21 Mar 2026.
Danish corporate and preclinical research-service oversight
Official investor leadership disclosure, Official Horsholm contact disclosure, Preclinical CRO operating claim
Preclinical CRO, Metabolic Disease Models, Peptide Therapeutics, and Drug Discovery Support
Gubra is published because official company materials confirm current leadership, Horsholm operating footprint, and a clear preclinical CRO and therapeutics platform.
Editorial note
Gubra is published because official company materials confirm current leadership, Horsholm operating footprint, and a clear preclinical CRO and therapeutics platform.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Preclinical Studies
Metabolic Disease Models
Drug Discovery Support
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Preclinical study infrastructure
Metabolic disease-model workflow
Drug-discovery support systems
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
21 Mar 2026: Executive identity confirmed via official management disclosure.
21 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is Gubra located?
- Gubra operates from Horsholm Kongevej 11B, 2970 Horsholm, Denmark, Horsholm, Denmark.
- Who runs Gubra?
- Gubra is led by Henrik Blou, CEO. Verified 21 Mar 2026.
- What does Gubra do?
- Gubra runs preclinical studies, metabolic disease models, and drug discovery support in Horsholm, Denmark. Core capabilities: Preclinical Studies, Metabolic Disease Models, Drug Discovery Support.
Editorial context
Related technical briefs
Briefs that name Horsholm as a covered market or city.